Press Releases from Crucell N.V. (NL) (4 total)
direct/ Crucell N.V. (NL) - PRESS EVENT - Crucell invites you to witness the con …
Crucell is pleased to invite you to witness a unique event - the construction of the Valerio Building - the only building of its kind in the world. Named after Crucell´s co-founder Dinko Valerio, the Valerio Building will be a state-of-the-art facility. The core of the facility consists of 64 modules that have been constructed off-site in Germany. Each module measures roughly 17.5 x 5.0 x 4.0 m (LxWxH) and…
direct/ Crucell N.V. (NL): Crucell Licenses STAR(TM) Technology to XOMA for Rese …
Leiden, The Netherlands, January 5, 2006 - Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL) announced today that it has signed a non-exclusive STAR(TM) research license agreement for the production of monoclonal antibodies and other proteins with Berkeley, California-based XOMA Ltd. (NASDAQ: XOMA). Financial details were not disclosed.
"XOMA regularly evaluates technologies that can help us stay at the cutting edge of antibody and recombinant protein technology," said Jack Castello,…
direct/ Crucell N.V. (NL) - Crucell Announces PER.C6(R) Licensing Agreement with …
Leiden, The Netherlands, December 8, 2005 - Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL) announced today that it has signed a PER.C6® research license agreement with German vaccine development company Vakzine Projekt Management (VPM) GmbH.
The non-exclusive agreement allows VPM to use the PER.C6® cell line to develop a vaccine to prevent a specific (undisclosed) infectious disease, and to develop diagnostics. VPM has also obtained an option to convert…
Crucell N.V. (NL) - Crucell Appoints Agents to Boost Asian Market Potential
Leiden, The Netherlands, September 20, 2005 - Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL) announced today that it has entered into agreements with Pharma&Soft in South Korea and Biott in Japan to increase the licensing business for PER.C6® and Advac® technology in Asia.
Under the contracts, the two agencies shall help Crucell to contact and secure agreements with prospective Korean and Japanese PER.C6® and Advac® licensees for the development…
